In inflammatory bowel disease (IBD), particularly Crohn’s disease, CRP levels correlate with disease activity [46], while in colorectal cancer (CRC), elevated CRP is associated with advanced stage and poor outcomes [47]. This evidence concerns the gene CRP and colorectal carcinoma.